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Abstract
Myeloid cell and hepatocyte IKKβmay mediate the genesis of obesity and insulin resistance
in mice fed high fat diet. However, their gender-specific roles in the pathogenesis of non-
alcoholic steatohepatitis (NASH) are not known. Here we demonstrate myeloid IKKβ defi-
ciency prevents Western diet-induced obesity and visceral adiposity in females but not in
males, and attenuates hyperglycemia, global IR, and NASH in both genders. In contrast, all
metabolic sequela including NASH are aggravated by hepatocyte IKKβ deficiency (IkbkbΔ-
hep) in male but not female mice. Gene profiling identifies sulfotransferase family 1E
(Sult1e1), which encodes a sulfotransferase E1 responsible for inactivation of estrogen, as
a gene upregulated in NASH in both genders and most conspicuously in male IkbkbΔhep
mice having worst NASH and lowest plasma estradiol levels. LXRα is enriched to LXRE on
Sult1e1 promoter in male WT and IkbkbΔhep mice with NASH, and a Sult1e1 promoter
activity is increased by LXRα and its ligand and augmented by expression of a S32A mutant
of IκBα. These results demonstrate striking gender differences in regulation by IKKβ of high
cholesterol saturated fat diet-induced metabolic changes including NASH and suggest
hepatocyte IKKβ is protective in male due at least in part to its ability to repress LXR-induced
Sult1e1. Our findings also raise a caution for systemic IKK inhibition for the treatment of
NASH as it may exacerbate the disease in male patients.
Introduction
Non-alcoholic fatty liver disease (NAFLD) including non-alcoholic steatohepatitis (NASH) is
the most prevalent liver disease in the world and is commonly associated with obesity and
insulin resistance (IR) [1–3]. Although the genetic and nutrient-deficient models such as that
with choline and methionine deficient diet, have been widely used for experimental studies, it
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is well recognized that these models do not reflect a natural history or course of NAFLD/
NASH seen in patients. To this end, different models have recently been developed which
emphasize the common etiological backgrounds such as overnutrition [4] and a diet high in
cholesterol and saturated fat (HCSF) [5–8].
Despite the obvious link between obesity, IR, and NASH, the precise mechanisms connect-
ing these sequela are not fully understood. Inflammation is recognized as a potential causal fac-
tor in developing IR [9, 10], and activation of IκB kinase β (IKKβ) and c-Jun N-terminal
kinase (JNK) are considered as critical effectors responsible for this causal link [11, 12]. The
cell type in which IKKβ is activated, appears important in inducing IR in different organ sites.
For instance, IKKβ in hepatocytes mediates diet-induced hepatic IR while that in myeloid cells
is responsible for global IR [13]. Activation of IKKβ associated with endoplasmic reticulum
(ER) stress in hypothalamus is recently shown to link overnutrition to suppressed insulin and
leptin signaling in this tissue, leading to energy imbalance, obesity, and glucose intolerance
[14]. Thus, these cell-type specific regulations by IKKβ appear to produce regional and sys-
temic effects on energy homeostasis and insulin sensitivity culminating to obesity-associated
IR. However, how these site-specific regulations actually relate to the pathogenesis of NASH is
not known.
Another outstanding question is the mechanism of the gender effect on diet-induced obe-
sity, IR, and NASH. Human and animal studies point to the importance of estrogen in energy
and metabolic homeostasis. Postmenopausal women are susceptible to visceral obesity, IR and
type 2 diabetes [15], and the treatment with 17β estradiol or conjugated estrogens attenuates
these complications [16, 17]. In fact, the incidence of diabetes among postmenopausal women
with hormone replacement therapy is significantly lower than those without [18] while the
prevalence of NAFLD is higher in women than men at the age of 55 years or older without the
therapy [19]. Conversely, among patients with persistent and unexplained elevations of serum
transaminases at the average age of 46 years, many of whom had NAFLD and NASH, female
gender was an independent factor associated with minimal liver lesions, suggesting that
NAFLD/NASH is less severe in female patients before menopause [20]. However, how the gen-
der affects the regulatory role of IKKβ in diet-induced obesity, IR and NASH, is completely
unknown.
In the present study, we have examined the effects of hepatocyte or myeloid specific IKKβ
deficiency on obesity, IR, and NAFLD/NASH induced by 20 wk feeding of a Western diet high
in cholesterol and saturated fat diet (HCFD) in both male and female mice. Indeed, the gender
has unique roles in influencing how IKKβ deficiency in these two cell types affects the meta-
bolic complications. Further, we identify the potential role of sulfotransferase 1 (Sult1e1) in
increased susceptibility for NASH in males particularly due to hepatocyte IKKβ deficiency.
Materials and methods
Animal experiments
Female and male C57BL/6J mice lacking IKKβ in hepatocytes (IkbkbΔhep) or myeloid cells
(IkbkbΔmye) [13] were obtained from Dr. Michael Karin (Department of Pharmacology and
Cancer Center University of California, San Diego, CA). C57BL/6/129 [21] and C57BL/6 [22]
Cre-recombinase transgenic mouse lines, respectively, were used to generate myeloid- and
hepatocyte-specific deleted IKKβ mice. These genetic deletions were confirmed to eliminate
IKKβ expression in either all hepatocytes (IkbkbΔhep) or 80–90% of macrophages and neutro-
phils (IkbkbΔmye) [13]. IKKβF/F mice without hepatocyte or myeloid specific expression of
Cre recombinase were used as wild type mice (Wt). All animals were treated in strict accor-
dance with the recommendations in the Guide for Care and Use of Laboratory Animals of the
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National Institutes of Health. The protocol was approved by the Institutional Animal Care and
Use Committee of the University of Southern California (Protocol Number: 10931). A HCFD
diet used contained 37.6% calories (Cal) from fat (Lard:20.9% Cal), 16.9% Cal from protein
(casein, L-Cystine), 45.5% Cal from carbohydrate (Sucrose, Cornstarch, Dextrose), Cholesterol
1% (w/w), vitamins and minerals (catalogue #180529, Dyets Inc., Bethlehem, PA). Standard
rodent chow (control diet) used contained 20.8% Cal from fat, 22.1% Cal from protein, 57.1%
Cal from carbohydrate (catalogue #S3888, Bio-Serv, Flemington, NJ). Mice were housed in a
specific pathogen-free facility (12 hours light/dark cycle) and were fed either standard rodent
chow or HCFD from 2.5 months of age for 20 wk or 12 months by the Animal Core of the
Southern California Research Center for ALPD and Cirrhosis.
Blood tests, glucose tolerance, and insulin sensitivity tests
Plasma glucose levels were determined by the GM7 Analyzer (Analox Instruments, Lunen-
burg, MA). Plasma ALT, insulin and adiponectin concentrations were measured by ELISA kits
(ALT: Sigma Diagnostic, St. Louis, MO, insulin: Shibayagi Co., Gunma, Japan, adiponectin:
ALPCO Diagnostics, Salem, NH, respectively). Mouse Estradiol in the plasma was determined
by the Hormone Assay Core of the Vanderbilt Diabetes Center using a Double Antibody 17β-
Estradiol RIA kit (MP Biomedicals, LLC Cat. # 07–138102). The assay was modified to
improve the sensitivity to 1 pg /ml. The inter assay coefficient of variation was 10 and 6% at
Mean = 4.5 and Mean = 22 pg/ml, respectively. After overnight fasting, glucose (1.5g/kg) or
insulin (1 U/kg) was injected intraperitoneally, and blood glucose was monitored with Preci-
sion-Xtra strips (Medisense Products, Bedford, MA) at 0, 15, 30, 60, 120 min as previously per-
formed [4].
Histology and immunostaining
Paraffin-embedded sections were stained with hematoxylin and eosin, and histology was
blindly scored for steatosis, inflammation, necrosis and lipo-granuloma by Morphology Core
of the Southern California Research Center for ALPD and Cirrhosis. Liver fibrosis was
assessed by reticulin staining and Sirius red staining. Formalin fixed sections of epididymal fat
were immunostained for tumor necrosis factor-α (TNFα) F4/80, and CD68 using goat poly-
clonal (catalogue #AF-410, R&D Systems. Minneapolis, MN), rat monoclonal antibody (cata-
logue #MCA497, AbD Serotec/Bio-Rad, Morpho Sys, UKLTD, Oxford, UK), and rabbit
polyclonal antibody (catalogue #sc-9139, Santa Cruz Biotech Inc, Santa Cruz, CA), respec-
tively. Liver histology scoring was blindly evaluated by a subspecialty gastrointestinal patholo-
gist as follows. Both micro-fat and macro-fat were individually scored according to the
following scale: “0”: no fat; “1”: fat in up to 25% of the hepatocytes, “2”: up to 50%, “3”: up to
75%, and “4”: greater than 75%. The micro-fat and macro-fat scores were summed to deter-
mine the combined fat-micro, macro score. Inflammation, necrosis, lipogranuloma, and reti-
culin (fibrosis) were individually scored according to the following scale: “0”: none; “1”:
minimal, “2”: mild, “3”: moderate, and “4”: severe (extensive). The inflammation and necrosis
scores were summed to determine the combined inflammation/necrosis score. Fat histology
scoring of inflammation in white adipose tissue (WAT) was also blindly evaluated by a subspe-
cialty gastrointestinal pathologist according to the following scale: “0”: no inflammatory foci;
“1”: minimal, “2”: mild, “3”: moderate, and “4”: severe (extensive) inflammatory foci.
Immunoblot analysis
Liver tissues were homogenized in RIPA buffer (PBS, pH 7.4, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS and complete protease inhibitor mixture). The protein extracts were
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resolved on a 10% GEL (SDS-PAGE), transferred onto a nitrocellulose membrane, then incu-
bated with primary antibodies followed by incubation with horseradish peroxidase-conjugated
secondary antibodies. The antigen-antibody complexes were visualized by the enhanced
chemiluminescence detection system (Thermo Scientific, Rockford, IL). Antibodies against
AMP kinase (AMPK), p-AMPK (Thr 172), JNK, p-JNK (catalogue #2532, #2531, #9252,
#4668, respectively) were obtained from Cell Signaling Technology Inc. (Danvers, MA),
nuclear form of sterol regulatory element binding protein-1c (nSREBP-1) (C-2) (catalogue
#sc-366) was from Santa Cruz Biotech Inc., peroxisome proliferator-activated receptor-δ
(PPARδ) antibody (catalogue #600-401-420) was purchased from Rockland Inc.(Gilbertsville,
PA). Anti-β-actin antibody (catalogue #A1978) was obtained from Sigma-Aldrich (St. Louis,
MO).
Real-time polymerase chain reaction and microarray analysis
Total RNA was extracted using TRIzol reagent by Invitrogen (Carlsbad, CA). Total RNA was
extracted from livers and white adipose tissue (WAT) using TRIzol reagent by Invitrogen. For
real time polymerase chain reaction (PCR) analysis for PPARα, PPARδ, PPARγ, adiponectin,
α1(I) procollagen, transforming growth factor-β (TGFβ1), CD68, TNFα, monocyte chemotac-
tic protein-1 (MCP-1), Nos2, Arg-1 (arginase-1), Ym/Chi3l3, Sult1e1, osteoactivin (Gpnmb),
the SYBR Green technique (Applied Biosystems, Foster City, CA) was used. Each Ct value was
normalized by the GAPDH. The PCR primers used for these genes are as follows: 5’-ACGA
TGCTGTCCTCCTTGATGand 5’-GTGTGATAAAGCCATTGCCGT (PPARα); 5’-GCTGCTG
CAGAAGATGGCA and 5’-CACTGCATCATCTGGGCATG (PPARδ); 5’-CCATTCTGGCCCA
CCAAC and 5’-AATGCGAGTGGTCTTCCATCA (PPARγ); 5’-AGAGATGGCACTCCTGGAG
AGAA and 5’-CAACATCTCCTGTCTCACCCTTA (adiponectin); 5’-GCATGGCCAAGAAG
ACATCC and 5’-CCTCGGGTTTCCACGTCTC(α1(I) procollagen); 5’-TTGCTTCAGCTCC
ACAGAGA and 5’-TGGTTGTAGAGGGCAAGGAC(TGFβ1); 5’-CCAATTCAGGGTGGAAGAAA
and 5’-TTGCATTTCCACAGCAGAAG (CD68); 5’-TACAGGCTTGTCACTCGAATT and 5’-
ATGAGCACAGAAAGCATGATC(TNFα); 5’-CCCAATGAGTAGGCTGGAGA and 5’-TCTGG
ACCCATTCCTTCTTG (MCP-1); 5’-GCCATTGCACAACTCTTTTC and 5’-GGAGAGGAGA
CTTCACAG (interleukin-6, or IL-6); 5’-CACCAAGCTGAACTTGAGCGA and 5’-CCATAGG
AAAAGACTGCACCGA (Nos2); 5’-CTCCAAGCCAAAGTCCTTAGAG and 5’-AGGAGCTG
TCATTAGGGACATC (Arg-1); 5’-AGGAAGCCCTCCTAAGGACA and 5’-ACGTCAATGAT
TCCTGCTCC (chitinase 3-like 3, or Ym1/Chi3l3); 5’-CTTCCAGCATCATTTTGGGAAAAG and
5’-TGGATTGTTCTTCATCTC(Sult1e1); 5’-TTCACTGTGACCTGCAAAGGAND 5’-CAGT
AGGTGCCAGACCCATT (Gpnmb). Microarray analysis was performed on liver RNA samples
using Mouse Genome 430 2.0 arrays (Affymetrix, Santa Clara, CA) at the USC/CHLA Genome
Core Laboratory.
Sult1e1 activity, promoter and ChIP analysis
SULT1E1 activity was determined using 35S-phosphoadenosine phosphosulfate (PerkinElmer,
Wellesley, MA) as previously described [23]. Chromatin isolated from liver tissues were ana-
lyzed for LXRα enrichment to a putative DR-4 of Sult1e1 gene (nt-121/-142: ataAGGTCA
agttTGCTCActc) by chromatin immunoprecipitation analysis (ChIP) and qPCR using the
primers, 5’-CCAAAGGGGAGAAACAGCTG-3’ and 5’-GAGAAGGAGGCAGAGACTC- GG
GGA as previously described [23]. Sult1e1 promoter activity was analyzed using tk- Sult1e1/
DR4 promoter-luciferase in HepG2 cells with or without expression of LXRα and/or a domi-
nant negative mutant (S32A) of IκBα, or treatment with TNFα. This tk-DR4 (mSult1e1)-Lucif-
erase construct is a heterologous reporter generated by inserting three copies of the DR4
Hepatocyte Ikkβ and gender difference in NASH
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(direct repeat spaced by 4 nucleotides) type nuclear receptor response element into the thymi-
dine kinase (tk)-Luciferase reporter gene; the DR4 sequence is (nt -121) ataAGGTCAagttTGC-
TACatc (nt -142), as previously described [23],
Data analysis
The numerical data were expressed as the means ±S.E.M. unless otherwise noted. ANOVA fol-
lowed by post-hoc Tukey test was performed for multiple comparisons denoting significant
differences with †p<0.05 and ††p<0.01, when appropriate. Student’s t-test was performed to
assess the statistical significance between two sets of data, as appropriate. p values less than
0.05 were considered significant as denoted by the asterisk.
Results
Obesity and visceral adiposity induced by HCFD are attenuated by
myeloid IKKβ deficiency in female but not male mice and aggravated by
hepatocyte IKKβ deficiency in males but not females
Feeding HCFD for 20 wk causes significant obesity in both male and female Wt mice as com-
pared to chow-fed (control) Wt mice (Fig 1A) despite comparable daily caloric intake of two
diets (mean ±S.D.: 17.4±2.5 for control males vs. 16.8±3.6 Cal/day for HCFD-fed males;14.2
±4.6 for control females vs. 13.2±4.7 Cal/day for HCFD-fed females). IKKβ deficiency in mye-
loid cells (IkbkbΔmye) almost completely prevents obesity in females but has no effects in
males (Fig 1A). In contrast, IKKβ deficiency in hepatocytes (IkbkbΔhep) aggravates HCFD-
induced obesity in males but not in females (Fig 1A). The total weight of visceral adipose tis-
sues shows similar gender-specific changes: prevention of a HCFD-induced increase in female
but not male IkbkbΔmye mice and aggravation of this parameter in male but not female
IkbkbΔhep mice (Fig 1B). Female IkbkbΔmye mice on chow diet also showed decreased visceral
adiposity compared to their Wt counterparts.
HCFD-induced hyperglycemia and global IR are attenuated by myeloid
IKKβ deficiency in females but aggravated in male mice by hepatocyte
IKKβ deficiency
HCFD feeding increases the fasting glucose levels in both male (mean ±S.D.: 100±21 vs. 142
±32 mg/dl, p<0.005) and female (75±10 vs. 105±16 mg/dl, p<0.005) WT mice. These hyper-
glycemias tend to be attenuated in male (121±34 mg/dl) and female (93±22 mg/dl) IkbkbΔmye
mice. Fasting hyperglycemia tends to be aggravated in male (158±22 mg/dl) but not female (92
±23 mg/dl) IkbkbΔhep mice. Fasting insulin levels are significantly elevated in HCFD-fed male
Wt mice compared to chow-fed male Wt mice (mean ±S.D.: 0.96±0.5 vs. 0.51±0.45 ng/ml,
p<0.05). This hyperinsulinemia tends to be corrected in IkbkbΔmye (0.64±0.42 ng/ml) but not
in IkbkbΔhep (0.97±0.59) mice. In females, plasma insulin levels are not different among differ-
ent genotypes and dietary groups. Glucose tolerance test reveals HCFD-fed female Wt mice
are glucose intolerant as compared to chow-fed Wt mice, and this effect is attenuated in
IkbkbΔmye mice (Fig 1C). Insulin sensitivity test demonstrates insulin resistance in both
female and male Wt mice fed HCFD. This effect is largely corrected in female and partially
ameliorated in male IkbkbΔmye mice (Fig 1D). On the other hand, insulin resistance is wors-
ened in male but not female IkbkbΔhep mice (Fig 1D). In summary, HCFD feeding causes obe-
sity, increased visceral adiposity, hyperglycemia, reduced glucose tolerance and insulin
resistance in both genders. IKKβ deficiency in myeloid cells clearly largely corrected these
Hepatocyte Ikkβ and gender difference in NASH
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Fig 1. Weight gain, visceral adiposity, and plasma glucose. Wild type (Wt), myeloid IKKβ deficient (IkbkbΔmye), or
hepatocyte IKKβ deficient (IkbkbΔhep) mice in both genders, were fed regular chow (Control) or high cholesterol and
saturated fat diet (HCFD) from 2.5 months of age for 20 weeks, and body weight gain (A) and visceral adiposity weight (B)
were determined. Visceral adiposity was determined by summing the individual measures of epidydimal/gonadal fat,
mesenteric fat, and retroperitoneal fat. Glucose tolerance (C) and insulin sensitivity (D) tests were also performed after
overnight fast. *p<0.05, **p<0.01, ***p<0.001 compared to Control diet within gender and within genotype by t-test.
†p<0.05, ††p<0.01 compared to other genotype within gender and within diet by ANOVA and post-hoc Tukey test.
https://doi.org/10.1371/journal.pone.0181052.g001
Hepatocyte Ikkβ and gender difference in NASH
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metabolic effects in females but only partially in males. On the contrary, IKKβ deficiency in
hepatocytes aggravates most of these effects in males but not in females.
NASH is attenuated in IkbkbΔmye mice in both genders but aggravated
in male but not female IkbkbΔhep mice
HCFD feeding results in hepatomegaly as assessed by the ratio of liver to body weight in male
but not female Wt mice. This effect is prevented in male IkbkbΔmye mice but worsened in
IkbkbΔhep mice (Fig 2A). Interestingly, both chow-fed male IkbkbΔmye and IkbkbΔhep mice
have increased ratio of liver to body weight compared with Wt mice of the same gender.
Plasma ALT levels are increased by HCFD feeding in Wt mice, and a higher elevation is
observed in male Wt mice than females (Fig 2B). These elevations associated with HCFD feed-
ing, are attenuated in IkbkbΔmye mice in both genders (Fig 2B). Histologically, HCFD feeding
causes macro and micro-vesicular steatosis, inflammation and necrosis in Wt mice in both
genders (Fig 2C). A typical histology of NASH seen in male Wt mice fed HCFD is shown in
Fig 2D as compared to normal histology in Wt control. The pathological changes of macro
and micro-vesicular steatosis induced by HCFD are attenuated in IkbkbΔmye female mice (Fig
2C). Real-time PCR results demonstrate that HCFD-induced NASH is associated with
increased expression of M1 macrophage activation genes such as TNFα and MCP-1 and
decreased expression of the M2 alternative activation gene arginase-1 (Arg-1) [24] in both gen-
ders (Fig 2E). The IkbkbΔmye genotype rescues the suppressive effect of HCFD on Arg-1 in
female but not in male mice. In fact, the expression of both Arg-1 and another M2 gene Ym-1/
Chi3l3, which encodes a heparin-binding lectin or chitinase 3-like 3 [25], are significantly
lower in male mice in all genotypes (Fig 2E). Expression of CD68, the marker for macro-
phages, is increased significantly in male Wt mice fed HCFD and this tends to increase further
in HCFD-fed IkbkbΔhep mice. IL-6 expression tends to be lower in males than in females in all
dietary and genotype groups, but is not affected by HCFD or genotypes.
HCFD feeding also induces liver fibrosis in Wt and IkbkbΔhep mice as demonstrated by Sir-
ius red and reticulin staining (Fig 3B–3F and data not shown). Pericellular and perisinusoidal
fibrosis are commonly observed. The fibrosis score as rated by reticulin staining reveals less
fibrosis in female Wt mice; attenuation in IkbkbΔmye mice in both genders; and aggravation
in male but not female IkbkbΔhep mice (Fig 2C). Minimal staining by Sirius red or reticulin
are noted in liver sections of a male Wt mouse fed chow for 5 months (Fig 3A and 3D). Sirius
red staining of liver section of a male Wt mouse fed HCFD for 5 months shows collagen depo-
sition forming bridges from the portal area (left) to the central vein (right) (Fig 3B). Sirius red
staining of a male Wt mouse fed HCFD for 12 months reveals the portal to central vein bridg-
ing fibrosis (Fig 3C). Reticulin staining of liver section from a male Wt mouse fed HCFD for 5
months depicts pericellular “Chicken wire” pattern of fibrosis typical of NASH (Fig 3E).
Another liver section of 5 months HCFD-fed Wt mouse stained for reticulin shows pericellular
fibrosis with clusters of PMNs at a higher magnification (Fig 3F). Expression of α1(I)procolla-
gen and the pro-fibrogenic cytokine, TGFβ1, mRNAs correlate with fibrotic changes.
Increased hepatic expression of α1(l)procollagen mRNA by 5-month HCFD feeding is noted
for male Wt mice, and tends to be attenuated in male IkbkbΔmye mice, but further enhanced
in male IkbkbΔhep mice. Expression of TGFβ1 is increased by 5-month HCFD in Wt mice of
both genders, and not affected by genotype on this diet (Fig 3G). For a subset of Wt male ani-
mals, we continued HCFD feeding for 12 months to determine a long-term effect on liver
fibrosis. Bridging liver fibrosis is evident in most of 12 month HCFD-fed mice (Fig 3C).
Hepatocyte Ikkβ and gender difference in NASH
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Fig 2. HCFD feeding produces NASH in Wt mice. Wild type (Wt), myeloid IKKβ deficient (IkbkbΔmye), or hepatocyte IKKβ deficient
(IkbkbΔhep) mice in both genders, were fed regular chow (Control) or high cholesterol and saturated fat diet (HCFD) from 2.5 months of
age for 20 weeks. (A) Hepatomegaly was assessed by the ratio of liver weight over body weight. (B) Plasma ALT was measured. (C)
Liver histological grading was determined for micro- and macro-vesicular steatosis, necroinflammation and lipogranuloma. Liver fibrosis
was assessed by analysis of reticulin staining. (D) Representative microphotograph of typical NASH induced in a HCFD-fed Wt male
mouse as compared to normal liver histology of a chow-fed male Wt mouse (Wt/Control, upper panels). (E) mRNA expressions in the
Hepatocyte Ikkβ and gender difference in NASH
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liver of M1 genes (TNFα, MCP-1), macrophage marker CD68, IL-6, and M2 genes (Arg-1 and Ym1/Ch3l3). *p<0.05, **p<0.01,
***p<0.001 compared to Control diet within gender and within genotype. †p<0.05, ††p<0.01 compared to other genotype within gender
and within diet.
https://doi.org/10.1371/journal.pone.0181052.g002
Fig 3. Liver fibrosis induced by HCFD. Liver fibrosis as assessed by Sirius red staining (A-C,
representative microphotographs), reticulin staining (D-F, representative microphotographs), or real-time
PCR for α1(l)procollagen and TGFβ1 mRNA (G). Wild type (Wt), myeloid IKKβ deficient (IkbkbΔmye), or
hepatocyte IKKβ deficient (IkbkbΔhep) mice were fed regular chow (Control) or high cholesterol and saturated
fat diet (HCFD) from 2.5 months of age for 20 weeks (A, B, and D-F) or 12 months (C). (A, C, D, E at x169
magnification; B and F at x338 magnification.) *p<0.05, **p<0.01 compared to Control diet within gender and
within genotype.
https://doi.org/10.1371/journal.pone.0181052.g003
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Enhanced lipogenic regulation by HCFD
HCFD feeding increases the hepatic levels of a nuclear (activated) form of SREBP-1c
(nSREBP-1c), a potent lipogenic transcription factor, in Wt mice in both genders but more
conspicuously in males (Fig 4A and 4B). HCFD does not affect the levels of p-AMPK and
PPARδ, both considered as anti-lipogenic and lipolytic regulators [26, 27], in male and female
Wt mice (Fig 4A and 4B). Expression of mRNA for PPARγ, another lipogenic transcription
factor, is increased in HCFD-fed Wt mice in females and tends to be increased in males, while
that for PPARα, another lipolytic transcription factor, tends to be reduced in male HCFD-fed
Wt mice (Fig 4D). In IkbkbΔmye mice, the increase in nSREBP-1c levels caused by HCFD is
attenuated in females (Fig 4A and 4B), and PPARγ mRNA tends to be reduced in males (Fig
4D). In addition, PPARα mRNA is normalized in male IkbkbΔmye mice-fed HCFD (Fig 4D).
More drastic changes are seen in HCFD-fed male IkbkbΔhep mice with aggravated NASH.
Firstly, p-AMPK and PPARδ protein levels are severely reduced, nSREBP-1c is most upregu-
lated, and p-JNK1 levels are clearly elevated (Fig 4A and 4B) while p-JNK2 tends to be
increased. In addition, PPARα mRNA tends to be further decreased in HCFD-fed male
IkbkbΔhep mice as compared to HCFD-fed Wt male mice (Fig 4D). Plasma levels of adiponec-
tin, an adipokine which serves as an activator of p-AMPK, are significantly lower in males
than in females within genotype and within diet (Fig 4C). In male IkbkbΔhep mice-fed HCFD,
the level is most reduced compared to other genotypes fed HCFD (Fig 4C). Thus, these results
demonstrate that HCFD-induced NASH in male Wt mice is associated with increased expres-
sion of lipogenic regulators (nSREBP-1c, PPARγ) and reduced lipolytic factor PPARα. These
changes are reversed by the IKKβ deficiency in myeloid cells in both genders and aggravated
only in males by the IKKβ deficiency in hepatocytes. Reduced AMPK activation perhaps at
least partially due to decreased plasma adiponectin levels and conversely increased JNK1/2
activation are also evident in aggravated NASH in male IkbkbΔhep mice.
WAT inflammation correlates with HCFD-induced NASH
WAT inflammation is suggested to be causally linked to obesity-associated IR [9, 10]. HCFD
feeding increases the frequency of inflammatory foci in WAT of both female and male Wt
mice (Fig 5I) as detected by H&E staining (Fig 5B) and confirmed by immunohistochemistry
for F4/80 (Fig 5D) and CD68 (Fig 5F) as compared to respective staining in WAT from chow-
fed Wt mice (Fig 5A, 5C and 5E). TNFα immunostaining in WAT is also increased by HCFD
feeding (Fig 5H) as compared to chow-fed Wt (Fig 5G). Real-time PCR analysis demonstrates
increased TNFα expression in WAT of both male and female HCFD-fed Wt mice, and a ten-
dency to further increment in this gene expression in male IkbkbΔhep mice (Fig 5J). Con-
versely, WAT adiponectin expression tends to be reduced by HCFD feeding in male but not
female Wt mice and tends to further decrease in male IkbkbΔhep mice (Fig 5J), corroborating
the reduced plasma adiponectin levels in this group (Fig 4C). Nos2, another M1 gene, is also
upregulated particularly in WAT of male HCFD-fed IkbkbΔhep mice in agreement with most
severe fat inflammation seen in these mice (Fig 5I). Arg-1 expression in WAT is uniformly
higher in male than female mice within genotype and within diet and is not affected by HCFD
or IKKβ deficiency.
Sulfotransferase family 1E (Sult1e1) and osteoactivin (Gpnmb) are
differentially induced in male but not female IkbkbΔhep mice fed HCFD
The hepatocyte IKKβ deficiency worsens HCFD-induced NASH in male but not female mice.
To help understand this gender difference, we have performed microarray analysis for liver
Hepatocyte Ikkβ and gender difference in NASH
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Fig 4. Upregulation of lipogenic genes and down-regulation of lipolytic genes associated with NASH induction and
aggravation. Wild type (Wt), myeloid IKKβ deficient (IkbkbΔmye), or hepatocyte IKKβ deficient (IkbkbΔhep) mice in both genders, were
fed regular chow (Control) or high cholesterol and saturated fat diet (HCFD) from 2.5 months of age for 20 weeks. (A) Immunoblotting of
whole liver lysate and (B) densitometric analysis of pAMPK/AMPK, nSREBP-1c, PPARδ, pJNK-1/JNK-1, and pJNK-2/JNK-2. (C)
Plasma adiponectin levels measured by ELISA. (D) Real-time PCR results of PPAR α, δ, and γ genes. *p<0.05, **p<0.01, ***p<0.001
compared to Control diet within gender and within genotype. †p<0.05, ††p<0.01 compared to other genotype within gender and within
diet.
https://doi.org/10.1371/journal.pone.0181052.g004
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Fig 5. Inflammation in epididymal fat tissue induced by HCFD in Wt mice of both genders and aggravated by
IkbkbΔhep in males. (A), (C), (E) and (G) are representative microphotographs from a male Wt mouse fed control diet
from 2.5 months of age for 20 weeks as opposed to (B), (D), (F) and (H) from a male IkbkbΔhep mouse fed HCFD with
aggravated NASH. Sections stained with H&E (x260). (B and D) Immunofluorescent staining for the macrophage marker
F4/80 (red) (x260). (E and F) Immunofluorescent staining for another macrophage marker CD 68 (green) (x260). (G and
H) Immunofluorescent staining for TNFα (green) (x260). (I) Fat histology scoring of inflammation in white adipose tissue
Hepatocyte Ikkβ and gender difference in NASH
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RNA samples from male and female Wt and IkbkbΔhep mice fed HCFD and determined genes
which are differentially regulated by IKKβ deficiency in male but not female mice as compared
to Wt mice. Table 1 shows partial lists of genes up-regulated or down-regulated by hepatocyte
IKKβ deficiency in males. (Complete gene lists are available online as supplementary informa-
tion, S1 and S2 Tables. In addition, the microarray data may be accessed online via the NIH
GEO website by using accession number GSE99031.) Among the genes up-regulated, Sult1e1
encodes sulfotransferase family E1 which is responsible for sulfation of estrogen, the first step
in inactivation and metabolism of this hormone [28]. Gpnmb encodes osteoactivin, a TGF-β
family of transmembrane glycoprotein which is expressed by macrophages and transformed
cells and implicated in inflammation including liver injury caused by CCl4 [29] or choline-
deficient diet [30], cell invasion and migration via MMP induction [30, 31]. Induction of
Sult1e1 by HCFD feeding tends to be attenuated in male IkbkbΔmye mice but further enhanced
in male but not female IkbkbΔhep mice (Fig 6A). Gpnmb induced by HCFD in Wt mice tends
to be suppressed in male IkbkbΔmye mice and accentuated ~3-fold in male but not female
IkbkbΔhep mice (Fig 6B).
SULT1E1 activity in the liver is increased by HCFD in both genders and further increased
only in male IkbkbΔhep mice (Fig 6D). As predicted, the plasma estradiol levels tend to be
reduced by HCFD feeding in both male and female Wt mice and further decreased in male but
not female IkbkbΔhep mice (Fig 6C), suggesting up-regulation of Sul1e1 and its activity are
responsible for reduced estradiol levels. As estradiol is known to protect from IR and hepatic
lipogenic regulation [32], these results suggest that heightened induction of Sult1e1 by HCFD
and IKKβ deficiency in male mice results in the lower circulating levels of estradiol and wors-
ening of IR and NASH in this gender. Sult1e1 induction observed in our model suggests a
LXR-mediated mechanism as our diet is high in cholesterol and Sult1e1 promoter is known to
contain functional LXRE [23]. To test the involvement of LXRα in Sult1e1 induction seen in
the models, we performed ChIP analysis for recruitment of this nuclear hormone receptor to
the Sult1e1 promoter with a putative DR4 sequence for LXRE [27]. LXRα enrichment to the
promoter is increased in the livers of male but not female Wt and IkbkbΔhep mice fed HCFD
(Fig 6E). We next performed a transfection-reporter analysis with a DR4(mSult1e1)-luciferase
construct in HepG2 cells. Expression of LXRα alone does not increase the promoter activity
(2nd vs. 1st bar, Fig 6F), but in the presence of the LXRα agonist GW3965, the activity is
increased 3-fold (6th bar). Expression of a dominant negative S32A mutant (DN) of IκBα
which blocks NF-κB activation, causes a marked increase in the promoter activity (4th bar)
while the treatment with TNFα which activates NF-κB, inhibits it (3rd bar) and attenuates the
increase caused by DN-IκBα (5th bar). Under the GW3965 treatment, similar patterns of the
effects of DN-IκBα and/or TNFα are observed. These results demonstrate that the Sult1e1 pro-
moter containing a putative DR-4 for LXRE, is under positive regulation of LXRα and its ago-
nist and negatively regulated by NF-κB. These findings suggest heightened induction of
Sult1e1 in the liver of male IkbkbΔhep mice, is due to a loss of the NF-κB mediated inhibition
of the gene.
Discussion
The present study demonstrates the gender-specific, differential regulatory roles of IKKβ in
myeloid cells and hepatocytes in obesity, IR, and NASH induced by HCFD in mice as
was determined by assessment of inflammatory foci. (J) Real-time PCR for TNFα, Nos2, adiponectin, and the M2 gene
Arg-1 in white adipose tissue. *p<0.05, **p<0.01 compared to Control diet within gender and within genotype. †p<0.05
compared to other genotype within gender and within diet.
https://doi.org/10.1371/journal.pone.0181052.g005
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summarized in Table 2. Key findings can be summarized as follows. Firstly, HCFD feeding to
adult C57Bl/6 mice results in a wide spectrum of metabolic syndrome as previously reported
[33], including obesity, visceral adiposity, hyperglycemia, global IR and NASH, and these com-
plications are generally more pronounced in males than females. Secondly, although myeloid
IKKβ deficiency corrects obesity and visceral adiposity in female but not male mice, it amelio-
rates fasting hyperglycemia, global IR, and steatohepatitis in both genders. Thirdly, hepatocyte
IKKβ deficiency aggravates all of these sequela in male, but not in female mice. These gender
specific differences are closely associated with: 1) lower plasma adiponectin levels in males
regardless of diet or genotype; 2) lower p-AMPK and higher nSRBP-1c in the livers of males
fed HCFD compared to females; 3) marked reductions in plasma adiponectin, hepatic p-
AMPK and PPARδ levels and conspicuous increases in nSREBP-1c and p-JNK1/2 in aggra-
vated NASH in male hepatic IKKβ deficient mice fed HCFD; 4) lower hepatic M2 gene (Arg1
and Chi3l3) expression in males than females regardless of diet or genotype; 5) further repres-
sion of these M2 genes in aggravated NASH in male hepatic IKKβ deficient mice; 6) inflamma-
tion in WAT associated with HCFD-induced NASH which is ameliorated by myeloid IKKβ
deficiency in females and aggravated by hepatic IKKβ deficiency in males.
Males are more susceptible to HCFD-induced NASH due possibly to lower plasma adipo-
nectin levels in general which may underlie their lipogenic propensity: induction of nSREBP-
1c and suppression of PPARα as a consequence of reduced adiponectin signaling in the liver
[34]. Indeed, the hepatic levels of p-AMPK, the effector intermediate molecule for anti-lipo-
genic adiponectin signaling, tended to be lower in males in our study. Another potential rea-
son for the susceptibility in male mice is lower expression of M2 genes such as Arg-1 and
Chi3l3 in the liver than females. When M1 genes (TNFα and MCP-1) are induced after HCFD
feeding, this relatively repressed expression of M2 genes may aggravate pro-inflammatory
response and the genesis of fatty liver as demonstrated by Odegaard, et al [35]. Certainly,
inflammation in WAT is tightly associated with HCFD-induced NASH and aggravation of this
pathology by hepatic IKKβ deficiency. In the latter condition, TNFα and NOS2 expression
Table 1. Differentially regulated genes in male vs. female IkbkbΔhep mice-fed HCFD*.
Change in Males Change in Females Gene ID: Code Gene Description
+2.1 -1.2 1053111: Sult1e1 Sulfotransferase family 1E
+1.73 -1.06 10574023: Mt1e Methallothionein 1E
+1.65 1 10407281: Esm1 Endothelial cell specific molecule 1
+1.61 1 10578352: Fgl1 Fibrinogen-like 1
+1.60 -2.1 10538187: Gpnmb Osteoactivin
+1.59 1 10551209: Cyp2b13 Cytochrome P450 2B13
+1.54 -1.53 10468239: Cyp17a1 Cytochrome P450 17A1
+1.52 -1.1 10357261: Macro Macrophage receptor with collagenous structure
-3.7 1 10566326: Trim12 Tripartite motif-containing 12
-2.0 1 10497349: Sirpb1 Signal-regulatory protein beta 1
-1.98 1 10392839: Cd300e CD300e antigen
-1.78 1 10351509: Fcgr4 Fc receptor, IgG, low affinity IV
-1.55 +1.1 10445953: Emr4 EGF-like molecule containing mucin-like, hormone receptor-like sequence 4
-1.53 +1.3 10562169:Hamp Hepcidin
*Four RNA samples from wildtype mice-fed HCFD and IkbkbΔhep mice-fed HCFD in both genders were pooled respectively, analyzed by Affymetrix
microarray, and compared against respective wildtype mouse samples in each gender.
Note: Liver tissue for microarray analysis was collected from mice fed HCFD for 20 weeks since 2.5 months of age.
https://doi.org/10.1371/journal.pone.0181052.t001
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Fig 6. Sult1e1 and Gpnmb are differentially up-regulated by IkbkbΔhep in males but not females fed HCFD. Wild type (Wt),
myeloid IKKβ deficient (IkbkbΔmye), or hepatocyte IKKβ deficient (IkbkbΔhep) mice in both genders, were fed regular chow (Control)
or high cholesterol and saturated fat diet (HCFD) from 2.5 months of age for 20 weeks (A-E). Real-time PCR of Sult1e1 (A) and
Gpnmb (B) expression. (C) Plasma estrogen levels assessed by double-antibody radioimmunoassay. (D) SULT1E1 activity assessed
by sulfotransferase assay carried out as previously described [23]. (E) Chromatin isolated from liver tissues were analyzed for LXRα
enrichment to a putative DR-4 of Sult1e1 gene as previously described [23]. (F) Sult1e1 promoter activity was analyzed using tk-DR4
(mSult1e1)-Luciferase construct in HepG2 cells with or without expression of LXRα and/or a dominant negative mutant (S32A) of
IκBα, or treatment with TNFα. [(A-E) *p<0.05, **p<0.01 compared to Control diet within gender and within genotype. †p<0.05,
††p<0.01 compared to other genotype within gender and within diet. (F) *p<0.05 between the compared data.]
https://doi.org/10.1371/journal.pone.0181052.g006
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were most upregulated with heightened inflammation, which could explain suppression of adi-
ponectin expression in WAT (Fig 5J). A question arises as to why IKKβ deficiency in hepato-
cytes leads to more inflammation in WAT. Is it because the livers of IKKβ deficient mice are
more inflamed and this causes inflammation in WAT? Or hepatic IKKβ deficiency aggravates
hepatic and global IR under HCFD feeding, and this in turn worsens WAT inflammation?
Although our study did not address this question, it has obvious pathogenetic significance and
warrants future investigations.
Our attempt to gain insights into the mechanisms underlying the gender difference in how
hepatic IKKβ deficiency influences HCFD-induced NASH, reveals differentially expressed
genes in males as opposed to females. Sult1e1 which encodes a sulfotransferase with high affin-
ity to estrogen, is such example and this gene is conspicuously induced in male but not female
mice due to hepatic IKKβ deficiency to the level which is ~150 fold higher than that seen in
male Wt mice fed chow. This also translated to the highest activity of this enzyme in HCFD-
fed male mice with hepatic IKKβ deficiency. This induction is due partly to HCFD feeding as
Wt mice fed HCFD have induced Sult1e1 mRNA and enzyme activity in both genders (Fig 6A
and 6D). Upregulation of Sult1e1 which is responsible for sulfation and inactivation of estro-
gen, is reported in db/db mice [36], and this may be mediated by LXR-dependent transactiva-
tion [23] as LXR is frequently induced in obesity and fatty livers [4]. Indeed, we observed
increased enrichment of LXRα to the Sult1e1 promoter in the livers of HCFD-fed male Wt and
IKKβ deficient mice (Fig 6E). We also show that suppression of NF-κB promotes LXRα-
dependent Sult1e1 promoter activity, and this most likely contributes to highly upregulated
Sult1e1 and its enzymatic activities in HCFD-fed male IKKβ deficient mice. There appears to
be reciprocal antagonism between NF-κB and LXR. LXR agonists inhibit many NF-κB respon-
sive genes via a mechanism which appear to acts downstream of NF-κB binding to DNA [37].
Conversely, agonists such as LPS and cytokines which activate NF-κB are known to repress
LXR expression [38]. Thus, the deficiency of IKKβ in hepatocytes may de-repress LXR expres-
sion resulting in enhancement of HCFD-induced Sult1e1 expression. This in turn, lowers cir-
culating levels of estradiol and compromises hepatoprotective effects of this hormone in
HCFD-fed male mice deficient in IKKβ in hepatocytes. Why this effect is not observed in
female mice is an important question for which we cannot offer any concrete notions
Table 2. Summary of changes in key metabolic parameters*.
Wt-fed HCFD IkbkbΔmye-fed HCFD IkbkbΔhep-fed HCFD
Female Male Female Male Female Male
Obesity " " — " " ""
Visceral Adiposity " " — " " ""
Hyperglycemia " " — — " ""
Global IR " " — " " ""
NASH " " — — " ""
Lipogenic genes " " — " " ""
Lipolytic genes — # — — — ##
p-JNK1/2 — — — — — "
Liver M1>M2 " " " " " ""
Adiponectin — # — — — ##
WAT Inflamm. " " — " " ""
*This table summarizes changes in the listed metabolic and pathologic parameters as compared to Wt mice fed chow (Wt control) in each gender.
A symbol “-”indicates no change from Wt control.
https://doi.org/10.1371/journal.pone.0181052.t002
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presently, but it may be related to the fact that Sult1e1 is expressed and regulated in a sexually
dimorphic manner [39].
In summary, our results revealed that the gender profoundly influences the way IKKβ in
myeloid cells or hepatocytes regulates the genesis or severity of HCFD-induced obesity, IR,
and NASH. Although myeloid IKKβ deficiency was beneficial for the most if not all of the met-
abolic consequences of HCFD feeding in both genders, hepatocyte IKKβ deficiency was detri-
mental in male but not female mice. This finding underscores the importance of careful
consideration for pharmacological IKKβ inhibition advocated for the treatment of NAFLD
and NASH [40] as this systemic approach most likely results in harmful effects of hepatocyte
IKKβ inhibition counteracting beneficial effects on myeloid cells.
Supporting information
S1 Table. Genes up-regulated by hepatocyte IKKβ deficiency in males but not in females.
(XLS)
S2 Table. Genes down-regulated by hepatocyte IKKβ deficiency in males but not females.
(XLS)
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